93 related articles for article (PubMed ID: 30648446)
1. Carbon nanospheres conjugated bisphosphonates: synthesis, characterization and in vitro antimalarial activity.
Dlamini NL; Mukaya HE; Van Zyl RL; Jansen van Vuuren NC; Mbianda XY
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S287-S296. PubMed ID: 30648446
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, kinetic drug release and anticancer activity of bisphosphonates multi-walled carbon nanotube conjugates.
Dlamini N; Mukaya HE; Van Zyl RL; Chen CT; Zeevaart RJ; Mbianda XY
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109967. PubMed ID: 31499981
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferase.
Špaček P; Keough DT; Chavchich M; Dračínský M; Janeba Z; Naesens L; Edstein MD; Guddat LW; Hocková D
J Med Chem; 2017 Sep; 60(17):7539-7554. PubMed ID: 28813147
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
[TBL] [Abstract][Full Text] [Related]
5. Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo.
Ghosh S; Chan JM; Lea CR; Meints GA; Lewis JC; Tovian ZS; Flessner RM; Loftus TC; Bruchhaus I; Kendrick H; Croft SL; Kemp RG; Kobayashi S; Nozaki T; Oldfield E
J Med Chem; 2004 Jan; 47(1):175-87. PubMed ID: 14695831
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, and antiplasmodial activity of polymer-incorporated aminoquinolines.
Aderibigbe BA; Neuse EW; Sadiku ER; Ray SS; Smith PJ
J Biomed Mater Res A; 2014 Jun; 102(6):1941-9. PubMed ID: 23853120
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors.
Murillo-Solano C; Dong C; Sanchez CG; Pizarro JC
Malar J; 2017 Jul; 16(1):292. PubMed ID: 28724415
[TBL] [Abstract][Full Text] [Related]
8. Interrogating alkyl and arylalkylpolyamino (bis)urea and (bis)thiourea isosteres as potent antimalarial chemotypes against multiple lifecycle forms of Plasmodium falciparum parasites.
Verlinden BK; de Beer M; Pachaiyappan B; Besaans E; Andayi WA; Reader J; Niemand J; van Biljon R; Guy K; Egan T; Woster PM; Birkholtz LM
Bioorg Med Chem; 2015 Aug; 23(16):5131-43. PubMed ID: 25684422
[TBL] [Abstract][Full Text] [Related]
9. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophoric studies of in vitro inhibition of Plasmodium falciparum growth.
Hariharan S
Indian J Biochem Biophys; 2012 Apr; 49(2):101-8. PubMed ID: 22650007
[TBL] [Abstract][Full Text] [Related]
11. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
Konziase B
J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
[TBL] [Abstract][Full Text] [Related]
12. Commercial drugs containing flavonoids are active in mice with malaria and in vitro against chloroquine-resistant Plasmodium falciparum.
Penna-Coutinho J; Aguiar AC; Krettli/ AU
Mem Inst Oswaldo Cruz; 2018 Dec; 113(12):e180279. PubMed ID: 30540020
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial acridines: synthesis, in vitro activity against P. falciparum and interaction with hematin.
Guetzoyan L; Yu XM; Ramiandrasoa F; Pethe S; Rogier C; Pradines B; Cresteil T; Perrée-Fauvet M; Mahy JP
Bioorg Med Chem; 2009 Dec; 17(23):8032-9. PubMed ID: 19879150
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine-astemizole hybrids with potent in vitro and in vivo antiplasmodial activity.
Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
Bioorg Med Chem Lett; 2009 Jan; 19(2):481-4. PubMed ID: 19054674
[TBL] [Abstract][Full Text] [Related]
15. Design, characterization and antimalarial efficacy of PEGylated galactosylated nano lipid carriers of primaquine phosphate.
Baruah UK; Gowthamarajan K; Ravisankar V; Karri VVSR; Simhadri PK; Singh V; Babu PP
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1809-1829. PubMed ID: 29087218
[TBL] [Abstract][Full Text] [Related]
16. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K
Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
[TBL] [Abstract][Full Text] [Related]
17. Preliminary LC-MS Based Screening for Inhibitors of Plasmodium falciparum Thioredoxin Reductase (PfTrxR) among a Set of Antimalarials from the Malaria Box.
Tiwari NK; Reynolds PJ; Calderón AI
Molecules; 2016 Mar; 21(4):424. PubMed ID: 27043496
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.
Kondaparla S; Soni A; Manhas A; Srivastava K; Puri SK; Katti SB
Bioorg Chem; 2017 Feb; 70():74-85. PubMed ID: 27908538
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and in vitro evaluation of novel enantiomerically-pure sulphonamide antimalarials.
Anusha S; Sinha A; Babu Rajeev CP; Chu TT; Mathai J; Ximei H; Fuchs JE; Shivananju N; Bender A; Preiser PR; Rangappa KS; Basappa ; Chandramohanadas R
Org Biomol Chem; 2015 Nov; 13(43):10681-90. PubMed ID: 26347024
[TBL] [Abstract][Full Text] [Related]
20. In vitro efficacy of 7-benzylamino-1-isoquinolinamines against Plasmodium falciparum related to the efficacy of chalcones.
Gutteridge CE; Hoffman MM; Bhattacharjee AK; Milhous WK; Gerena L
Bioorg Med Chem Lett; 2011 Jan; 21(2):786-9. PubMed ID: 21168330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
